Skip to main content

Table 1 Clinical characteristics of study population

From: Placental 13C-DHA metabolism and relationship with maternal BMI, glycemia and birthweight

Clinical characteristics Total (n = 17) Non-GDM (n = 8) GDM (n = 9)
Maternal age (years) 33.4 (2.9) 32.5 (2.6) 34.1 (3.2)
Chinese: Indian ethnicity 11 (65%): 6 (35%) 6 (75%): 2 (25%) 5 (56%): 4 (44%)
Maternal BMI in first trimester (kg/m2) 25.4 (4.6) 24.1 (3.9) 26.6 (5)
Normal weight: Overweight: Obesea 5 (29%): 6 (35%): 6 (35%) 3 (38%): 2 (25%): 3 (38%) 2 (22%): 4 (44%): 3 (33%)
Fasting glycemia (mmol/L)b 4.5 (0.5) 4.4 (0.2) 4.6 (0.6)
1-h glycemia (mmol/L)b 9.0 (1.7) 7.8 (1.4) 10.1 (1.15)
2-h glycemia (mmol/L)b 7.6 (1.6) 6.4 (0.9) 8.8 (1.2)
Antenatal PUFA-containing supplementation 6 (35%) 3 (33%) 3 (38%)
Gestational age at delivery (days) 271.4 (5.9) 273.3 (7.4) 269.7 (3.7)
Female neonates 9 (52%) 4 (50%) 5 (56%)
Birthweight (g) 3276.0 (323) 3298.1 (326) 3255.6 (339)
Birthweight centile (%)c 61 (30) 59 (31) 66 (31)
  1. Data presented as Mean (SD) or n (%)
  2. aWHO recommended Asian-specific BMI cut-off that is associated with increased metabolic risk (WHO EC 2004): Normal 18.5–22.9 kg/m2, Overweight 23–27.4 kg/m2, Obese ≥ 27.5 kg/m2
  3. bIn mid-gestation 75 g three time-point OGTT
  4. cBy local sex and gestational age-standardized references